The number of cancer survivors in the U.S. is projected to grow by 31 percent in just a decade—from 15.5 million to 20.3 million. While rapid scientific advances are increasing survival, they’re also adding complexity to treatment decisions. Studies show wide variations in the extent to which doctors follow evidence-based care recommendations. Meanwhile, the cost of cancer care is growing faster than costs in any other medical sector, with price tags on new cancer drugs playing a major role.

For these reasons and more, the new frontiers of cancer treatment must include better ways to deliver and pay for care. This webinar will explore:

• The implications of cancer drug innovations for patients, payers and the FDA
• How an oncology-specific accountable care organization in Florida is flattening the rate of cancer care cost growth
• CMS’s episode-based Oncology Care Model, an ongoing pilot involving over a dozen payers and nearly 200 provider practices
• Research-informed efforts to reduce use of cancer services that are low-benefit or even harmful
• The urgent need for a more supportive care ecosystem for cancer patients

For additional information, speakers, and registration, click here.